Global Mouse Epidermal Growth Factor Reagent Market Growth 2025-2031

Publication ID:

LPI07254804

Publication Date:

July 24, 2025

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Mouse Epidermal Growth Factor Reagent market size is predicted to grow from US$ 100 million in 2025 to US$ 186 million in 2031; it is expected to grow at a CAGR of 10.9% from 2025 to 2031.
Epidermal growth factor (EGF) is a small, potent growth factor that induces cell proliferation, differentiation, and survival. EGF is the founding member of the EGF family, which also includes TGF-alpha, amphiregulin (AR), betacellulin (BTC), epiregulin (EPR), heparin-binding EGF-like growth factor (HB EGF), epidermal factor, and neuregulin (NRG)-1 to -6. EGF family members are characterized by a common structural motif, the EGF-like domain, which contains three intramolecular disulfide bonds formed by six similarly spaced, conserved cysteine 鈥嬧€媟esidues. These disulfide bonds are essential for proper protein conformation and receptor binding.
United States market for Mouse Epidermal Growth Factor Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Mouse Epidermal Growth Factor Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Mouse Epidermal Growth Factor Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Mouse Epidermal Growth Factor Reagent players cover Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淢ouse Epidermal Growth Factor Reagent Industry Forecast鈥� looks at past sales and reviews total world Mouse Epidermal Growth Factor Reagent sales in 2024, providing a comprehensive analysis by region and market sector of projected Mouse Epidermal Growth Factor Reagent sales for 2025 through 2031. With Mouse Epidermal Growth Factor Reagent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mouse Epidermal Growth Factor Reagent industry.
This Insight Report provides a comprehensive analysis of the global Mouse Epidermal Growth Factor Reagent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mouse Epidermal Growth Factor Reagent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Mouse Epidermal Growth Factor Reagent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mouse Epidermal Growth Factor Reagent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mouse Epidermal Growth Factor Reagent.
This report presents a comprehensive overview, market shares, and growth opportunities of Mouse Epidermal Growth Factor Reagent market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
笔耻谤颈迟测锛�95%
笔耻谤颈迟测鈮�95%
Segmentation by Application:
Biological Laboratories
University
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novartis
Amgen
Betta Pharmaceuticals
Thermo Fisher Scientific Inc.
Eli Lilly and Company
Bio-Techne
Merck
Yeasen
Sino Biological
Miltenyi Biotec
Proteintech
BioLegend
Key Questions Addressed in this Report
What is the 10-year outlook for the global Mouse Epidermal Growth Factor Reagent market?
What factors are driving Mouse Epidermal Growth Factor Reagent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mouse Epidermal Growth Factor Reagent market opportunities vary by end market size?
How does Mouse Epidermal Growth Factor Reagent break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mouse Epidermal Growth Factor Reagent Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mouse Epidermal Growth Factor Reagent by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mouse Epidermal Growth Factor Reagent by Country/Region, 2020, 2024 & 2031
2.2 Mouse Epidermal Growth Factor Reagent Segment by Type
2.2.1 笔耻谤颈迟测锛�95%
2.2.2 笔耻谤颈迟测鈮�95%
2.3 Mouse Epidermal Growth Factor Reagent Sales by Type
2.3.1 Global Mouse Epidermal Growth Factor Reagent Sales Market Share by Type (2020-2025)
2.3.2 Global Mouse Epidermal Growth Factor Reagent Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mouse Epidermal Growth Factor Reagent Sale Price by Type (2020-2025)
2.4 Mouse Epidermal Growth Factor Reagent Segment by Application
2.4.1 Biological Laboratories
2.4.2 University
2.4.3 Others
2.5 Mouse Epidermal Growth Factor Reagent Sales by Application
2.5.1 Global Mouse Epidermal Growth Factor Reagent Sale Market Share by Application (2020-2025)
2.5.2 Global Mouse Epidermal Growth Factor Reagent Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mouse Epidermal Growth Factor Reagent Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Mouse Epidermal Growth Factor Reagent Breakdown Data by Company
3.1.1 Global Mouse Epidermal Growth Factor Reagent Annual Sales by Company (2020-2025)
3.1.2 Global Mouse Epidermal Growth Factor Reagent Sales Market Share by Company (2020-2025)
3.2 Global Mouse Epidermal Growth Factor Reagent Annual Revenue by Company (2020-2025)
3.2.1 Global Mouse Epidermal Growth Factor Reagent Revenue by Company (2020-2025)
3.2.2 Global Mouse Epidermal Growth Factor Reagent Revenue Market Share by Company (2020-2025)
3.3 Global Mouse Epidermal Growth Factor Reagent Sale Price by Company
3.4 Key Manufacturers Mouse Epidermal Growth Factor Reagent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mouse Epidermal Growth Factor Reagent Product Location Distribution
3.4.2 Players Mouse Epidermal Growth Factor Reagent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Mouse Epidermal Growth Factor Reagent by Geographic Region
4.1 World Historic Mouse Epidermal Growth Factor Reagent Market Size by Geographic Region (2020-2025)
4.1.1 Global Mouse Epidermal Growth Factor Reagent Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mouse Epidermal Growth Factor Reagent Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mouse Epidermal Growth Factor Reagent Market Size by Country/Region (2020-2025)
4.2.1 Global Mouse Epidermal Growth Factor Reagent Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mouse Epidermal Growth Factor Reagent Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mouse Epidermal Growth Factor Reagent Sales Growth
4.4 APAC Mouse Epidermal Growth Factor Reagent Sales Growth
4.5 Europe Mouse Epidermal Growth Factor Reagent Sales Growth
4.6 Middle East & Africa Mouse Epidermal Growth Factor Reagent Sales Growth
5 Americas
5.1 Americas Mouse Epidermal Growth Factor Reagent Sales by Country
5.1.1 Americas Mouse Epidermal Growth Factor Reagent Sales by Country (2020-2025)
5.1.2 Americas Mouse Epidermal Growth Factor Reagent Revenue by Country (2020-2025)
5.2 Americas Mouse Epidermal Growth Factor Reagent Sales by Type (2020-2025)
5.3 Americas Mouse Epidermal Growth Factor Reagent Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mouse Epidermal Growth Factor Reagent Sales by Region
6.1.1 APAC Mouse Epidermal Growth Factor Reagent Sales by Region (2020-2025)
6.1.2 APAC Mouse Epidermal Growth Factor Reagent Revenue by Region (2020-2025)
6.2 APAC Mouse Epidermal Growth Factor Reagent Sales by Type (2020-2025)
6.3 APAC Mouse Epidermal Growth Factor Reagent Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mouse Epidermal Growth Factor Reagent by Country
7.1.1 Europe Mouse Epidermal Growth Factor Reagent Sales by Country (2020-2025)
7.1.2 Europe Mouse Epidermal Growth Factor Reagent Revenue by Country (2020-2025)
7.2 Europe Mouse Epidermal Growth Factor Reagent Sales by Type (2020-2025)
7.3 Europe Mouse Epidermal Growth Factor Reagent Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mouse Epidermal Growth Factor Reagent by Country
8.1.1 Middle East & Africa Mouse Epidermal Growth Factor Reagent Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mouse Epidermal Growth Factor Reagent Revenue by Country (2020-2025)
8.2 Middle East & Africa Mouse Epidermal Growth Factor Reagent Sales by Type (2020-2025)
8.3 Middle East & Africa Mouse Epidermal Growth Factor Reagent Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mouse Epidermal Growth Factor Reagent
10.3 Manufacturing Process Analysis of Mouse Epidermal Growth Factor Reagent
10.4 Industry Chain Structure of Mouse Epidermal Growth Factor Reagent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mouse Epidermal Growth Factor Reagent Distributors
11.3 Mouse Epidermal Growth Factor Reagent Customer
12 World Forecast Review for Mouse Epidermal Growth Factor Reagent by Geographic Region
12.1 Global Mouse Epidermal Growth Factor Reagent Market Size Forecast by Region
12.1.1 Global Mouse Epidermal Growth Factor Reagent Forecast by Region (2026-2031)
12.1.2 Global Mouse Epidermal Growth Factor Reagent Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mouse Epidermal Growth Factor Reagent Forecast by Type (2026-2031)
12.7 Global Mouse Epidermal Growth Factor Reagent Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.1.3 Novartis Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.2.3 Amgen Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Betta Pharmaceuticals
13.3.1 Betta Pharmaceuticals Company Information
13.3.2 Betta Pharmaceuticals Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.3.3 Betta Pharmaceuticals Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Betta Pharmaceuticals Main Business Overview
13.3.5 Betta Pharmaceuticals Latest Developments
13.4 Thermo Fisher Scientific Inc.
13.4.1 Thermo Fisher Scientific Inc. Company Information
13.4.2 Thermo Fisher Scientific Inc. Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Inc. Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Thermo Fisher Scientific Inc. Main Business Overview
13.4.5 Thermo Fisher Scientific Inc. Latest Developments
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Information
13.5.2 Eli Lilly and Company Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.5.3 Eli Lilly and Company Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Eli Lilly and Company Main Business Overview
13.5.5 Eli Lilly and Company Latest Developments
13.6 Bio-Techne
13.6.1 Bio-Techne Company Information
13.6.2 Bio-Techne Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.6.3 Bio-Techne Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bio-Techne Main Business Overview
13.6.5 Bio-Techne Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.7.3 Merck Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Yeasen
13.8.1 Yeasen Company Information
13.8.2 Yeasen Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.8.3 Yeasen Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Yeasen Main Business Overview
13.8.5 Yeasen Latest Developments
13.9 Sino Biological
13.9.1 Sino Biological Company Information
13.9.2 Sino Biological Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.9.3 Sino Biological Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sino Biological Main Business Overview
13.9.5 Sino Biological Latest Developments
13.10 Miltenyi Biotec
13.10.1 Miltenyi Biotec Company Information
13.10.2 Miltenyi Biotec Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.10.3 Miltenyi Biotec Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Miltenyi Biotec Main Business Overview
13.10.5 Miltenyi Biotec Latest Developments
13.11 Proteintech
13.11.1 Proteintech Company Information
13.11.2 Proteintech Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.11.3 Proteintech Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Proteintech Main Business Overview
13.11.5 Proteintech Latest Developments
13.12 BioLegend
13.12.1 BioLegend Company Information
13.12.2 BioLegend Mouse Epidermal Growth Factor Reagent Product Portfolios and Specifications
13.12.3 BioLegend Mouse Epidermal Growth Factor Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 BioLegend Main Business Overview
13.12.5 BioLegend Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂